Levi v. United States
This text of 140 F. 126 (Levi v. United States) is published on Counsel Stack Legal Research, covering U.S. Circuit Court for the District of Southern New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
(orally). The merchandise in question, known as “chrysarobin,” was assessed for duty by the Collector of Customs as a medicinal preparation, under Tariff Act July 24, 1897, c. 11, § 1, Schedule A, par. 68, 30 Stat. 154 [U. S. Comp. St. 1901, p. 1631], and is claimed by the importer as properly dutiable under paragraph 20 (30 Stat. 152 [U. S. Comp. St. 1901, p. 1628]) of the same act as a “drug advanced in value,” etc. This case is controlled by the decision of the Circuit Court of Appeals 'for this circuit in United States v. Merck (T. D. 20,046) 136 Fed. 817.
The decision of the Board of General Appraisers is reversed.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
140 F. 126, 1905 U.S. App. LEXIS 4772, Counsel Stack Legal Research, https://law.counselstack.com/opinion/levi-v-united-states-circtsdny-1905.